These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34951423)

  • 1. Anthracyclines: biosynthesis, engineering and clinical applications.
    Hulst MB; Grocholski T; Neefjes JJC; van Wezel GP; Metsä-Ketelä M
    Nat Prod Rep; 2022 Apr; 39(4):814-841. PubMed ID: 34951423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.
    Wander DPA; van der Zanden SY; van der Marel GA; Overkleeft HS; Neefjes J; Codée JDC
    J Med Chem; 2020 Nov; 63(21):12814-12829. PubMed ID: 33064004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin.
    Pang B; Qiao X; Janssen L; Velds A; Groothuis T; Kerkhoven R; Nieuwland M; Ovaa H; Rottenberg S; van Tellingen O; Janssen J; Huijgens P; Zwart W; Neefjes J
    Nat Commun; 2013; 4():1908. PubMed ID: 23715267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
    Gruber BM; Anuszewska EL; Bubko I; Goździk A; Fokt I; Priebe W
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):193-8. PubMed ID: 17557149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells.
    Vavrova A; Jansova H; Mackova E; Machacek M; Haskova P; Tichotova L; Sterba M; Simunek T
    PLoS One; 2013; 8(10):e76676. PubMed ID: 24116135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives.
    Marinello J; Delcuratolo M; Capranico G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Pot Combinatorial Biosynthesis of Glycosylated Anthracyclines by Cocultivation of Streptomyces Strains Producing Aglycones and Nucleotide Deoxysugars.
    Kim E; Song MC; Kim MS; Beom JY; Jung JA; Cho HS; Yoon YJ
    ACS Comb Sci; 2017 Apr; 19(4):262-270. PubMed ID: 28191923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction model for anthracycline activity against DNA topoisomerase II.
    Moro S; Beretta GL; Dal Ben D; Nitiss J; Palumbo M; Capranico G
    Biochemistry; 2004 Jun; 43(23):7503-13. PubMed ID: 15182192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
    Gruber BM; Anuszewska EL; Bubko I; Gozdzik A; Priebe W; Fokt I
    Anticancer Res; 2005; 25(3B):2193-8. PubMed ID: 16158963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage independent inhibition of NF-κB transcription by anthracyclines.
    Chora AF; Pedroso D; Kyriakou E; Pejanovic N; Colaço H; Gozzelino R; Barros A; Willmann K; Velho T; Moita CF; Santos I; Pereira P; Carvalho S; Martins FB; Ferreira JA; de Almeida SF; Benes V; Anrather J; Weis S; Soares MP; Geerlof A; Neefjes J; Sattler M; Messias AC; Neves-Costa A; Moita LF
    Elife; 2022 Dec; 11():. PubMed ID: 36476511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms of anthracyclines action].
    Szuławska A; Czyz M
    Postepy Hig Med Dosw (Online); 2006; 60():78-100. PubMed ID: 16489295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic (
    Wander DPA; van der Zanden SY; Vriends MBL; van Veen BC; Vlaming JGC; Bruyning T; Hansen T; van der Marel GA; Overkleeft HS; Neefjes JJC; Codée JDC
    J Org Chem; 2021 Apr; 86(8):5757-5770. PubMed ID: 33783212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity.
    Mordente A; Meucci E; Martorana GE; Tavian D; Silvestrini A
    Curr Med Chem; 2017; 24(15):1607-1626. PubMed ID: 27978799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
    Qiao X; van der Zanden SY; Wander DPA; Borràs DM; Song JY; Li X; van Duikeren S; van Gils N; Rutten A; van Herwaarden T; van Tellingen O; Giacomelli E; Bellin M; Orlova V; Tertoolen LGJ; Gerhardt S; Akkermans JJ; Bakker JM; Zuur CL; Pang B; Smits AM; Mummery CL; Smit L; Arens R; Li J; Overkleeft HS; Neefjes J
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15182-15192. PubMed ID: 32554494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway Engineering of Anthracyclines: Blazing Trails in Natural Product Glycodiversification.
    Brown KV; Wandi BN; Metsä-Ketelä M; Nybo SE
    J Org Chem; 2020 Oct; 85(19):12012-12023. PubMed ID: 32938175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology.
    Bayles CE; Hale DE; Konieczny A; Anderson VD; Richardson CR; Brown KV; Nguyen JT; Hecht J; Schwartz N; Kharel MK; Amissah F; Dowling TC; Nybo SE
    Toxicol Appl Pharmacol; 2023 Jan; 459():116362. PubMed ID: 36592899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition.
    Hasinoff BB; Patel D; Wu X
    Toxicol Appl Pharmacol; 2020 Jul; 399():115038. PubMed ID: 32417440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aromatic polyketides from soil Streptomyces spp.: purification, characterization and bioactivity studies.
    Bundale S; Begde D; Pillai D; Gangwani K; Nashikkar N; Kadam T; Upadhyay A
    World J Microbiol Biotechnol; 2018 Apr; 34(5):67. PubMed ID: 29691661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Streptomyces venezuelae-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates.
    Han AR; Park JW; Lee MK; Ban YH; Yoo YJ; Kim EJ; Kim E; Kim BG; Sohng JK; Yoon YJ
    Appl Environ Microbiol; 2011 Jul; 77(14):4912-23. PubMed ID: 21602397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin.
    Stepankova J; Studenovsky M; Malina J; Kasparkova J; Liskova B; Novakova O; Ulbrich K; Brabec V
    Biochem Pharmacol; 2011 Aug; 82(3):227-35. PubMed ID: 21570955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.